Applied Genetic Technologies Corporation is a biotechnology company specializing in gene therapy products for inherited orphan ophthalmology diseases in the United States. The company's lead product candidates include treatments for X-linked retinoschisis, Congenital Achromatopsia, and X-linked retinitis pigmentosa, which are eye diseases caused by mutations in single genes. The company is currently in the clinical stage of development.